Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Cannabinoids in the management of difficult to treat pain

Authors Ethan B Russo

Published 8 February 2008 Volume 2008:4(1) Pages 245—259


Ethan B Russo

GW Pharmaceuticals, Vashon, WA, USA

Abstract: This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized clinical trials employing cannabinoids in pain treatment. Tetrahydrocannabinol (THC, Marinol®) and nabilone (Cesamet®) are currently approved in the United States and other countries, but not for pain indications. Other synthetic cannabinoids, such as ajulemic acid, are in development. Crude herbal cannabis remains illegal in most jurisdictions but is also under investigation. Sativex®, a cannabis derived oromucosal spray containing equal proportions of THC (partial CB1 receptor agonist) and cannabidiol (CBD, a non-euphoriant, anti-inflammatory analgesic with CB1 receptor antagonist and endocannabinoid modulating effects) was approved in Canada in 2005 for treatment of central neuropathic pain in multiple sclerosis, and in 2007 for intractable cancer pain. Numerous randomized clinical trials have demonstrated safety and efficacy for Sativex in central and peripheral neuropathic pain, rheumatoid arthritis and cancer pain. An Investigational New Drug application to conduct advanced clinical trials for cancer pain was approved by the US FDA in January 2006. Cannabinoid analgesics have generally been well tolerated in clinical trials with acceptable adverse event profiles. Their adjunctive addition to the pharmacological armamentarium for treatment of pain shows great promise.

Keywords: cannabinoids, tetrahydrocannabinol, cannabidiol, analgesia, pain management, multiple sclerosis

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Evaluation of calcified carotid atheroma on panoramic radiographs and Doppler ultrasonography in an older population

Atalay Y, Asutay F, Agacayak KS, Koparal M, Adali F, Gulsun B

Clinical Interventions in Aging 2015, 10:1121-1129

Published Date: 8 July 2015

Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery

Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D

International Journal of Nanomedicine 2015, 10:2101-2114

Published Date: 16 March 2015

Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro

Wang S, Wang YH, Liu J, Shao SX, Li XJ, Gao JN, Niu HT, Wang XS

OncoTargets and Therapy 2014, 7:1389-1396

Published Date: 5 August 2014

Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging

Li D, Tang X, Pulli B, Lin C, Zhao P, Cheng J, Lv Z, Yuan X, Luo Q, Cai H, Ye M

International Journal of Nanomedicine 2014, 9:3347-3361

Published Date: 10 July 2014

HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma

Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR

OncoTargets and Therapy 2014, 7:1061-1070

Published Date: 13 June 2014

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis

Ege Can Serefoglu, Zafer Tandogdu

Therapeutics and Clinical Risk Management 2010, 6:219-223

Published Date: 16 May 2010

Clinical presentation of anxiety among patients with epilepsy

M López-Gómez, M Espinola, J Ramirez-Bermudez, I E Martinez-Juarez, A L Sosa

Neuropsychiatric Disease and Treatment 2008, 4:1235-1239

Published Date: 5 December 2008

Topotecan in the treatment of relapsed small cell lung cancer

Elisabeth Quoix

OncoTargets and Therapy 2008, 1:79-86

Published Date: 1 December 2008

Differential effects of acute diazepam on emotional and neutral memory tasks in acutely hospitalized depressed patients

Vera B Delgado, Ivan Izquierdo, Márcia LF Chaves

Neuropsychiatric Disease and Treatment 2005, 1:269-275

Published Date: 15 October 2005